Please click and read this disclaimer if you wish to continue with the contents below. Bench marking myself against STI, HKSE and World Index: For last month's portfolio review click here  Year to date: STI Index: -19.27% HK Index: -7.62% My Portfolio: -4.92% World Index: +5.70% Three years trailing: STI Index: -17.92% HK Index: -3.84% World Index: +20.89% My Portfolio: +12.38% Year to date, I outperformed STI by 14.35% and HK by 2.7%, under performed the World Index by 10.62%. Three years trailing, I outperformed STI by 30.3% and HK by 16.22%, under performed the World Index by 8.51%. Portfolio composition: Transactions: Bought JXR(HK:1951) 4.21% weightage Bought more Netease(HK:9999) to 4.35% weightage Bought Frontage(HK:1521) to 3.06% Bought Genscript Bio(HK:1548) to 2.76% Took profit for XD(HK:2400) Took profit for Pacific Century(SGX:P15) For more in depth detail refer to my portfolio tab here Commentary: Global markets continues to be cautious with tech stocks taking the center stage. Especially asset light fully scale-able Saas companies....